GTHRinactive

GENETHERA INC

Healthcare·Infectious Disease·Pre-clinical
Infectious Disease

GENETHERA INC (GTHR): 5 pipeline candidates. Updated within the last hour.

6.8/10

BioSniper Score

3-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial Health10.0

D/E -1.00 · 0% dilution

Pipeline Maturity2.0

Lead: Preclinical

Pipeline Breadth8.5

5 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for GENETHERA INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

—

Cash

—

Quarterly Burn

$125K

Runway

—

Revenue

—

Pipeline (5 candidates)

DrugPhase
chronic wasting disease vaccinePreclinical
e. coli o157:h7 vaccinePreclinical
herdsafePreclinical
map vaccinePreclinical
sars-cov-2 vaccinePreclinical

Frequently asked questions

How many drug candidates are in GENETHERA INC's pipeline?

GENETHERA INC (GTHR) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is GENETHERA INC's lead drug candidate?

GENETHERA INC's most advanced tracked candidate is chronic wasting disease vaccine (Preclinical) for Chronic Wasting Disease.

Get the full picture on GENETHERA INC

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar